Pyrrolo [ 2, 3 - d] pyrimidine urea compounds as JAK inhibitors

Details for Australian Patent Application No. 2011213198 (hide)

Owner Pfizer Inc.

Inventors Johnson, Timothy Allen; Fenwick, Ashley; Kyne, Graham M.

Agent Allens Patent & Trade Mark Attorneys

Pub. Number AU-A-2011213198

PCT Pub. Number WO2011/097087

Priority 61/301,915 05.02.10 US

Filing date 24 January 2011

Wipo publication date 11 August 2011

International Classifications

C07D 487/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/519 - ortho- or peri-condensed with heterocyclic rings

A61P 11/00 Drugs for disorders of the respiratory system

A61P 19/02 Drugs for skeletal disorders

A61P 25/08 Drugs for disorders of the nervous system

A61P 25/28 Drugs for disorders of the nervous system

A61P 27/02 Drugs for disorders of the senses

A61P 35/00 Antineoplastic agents

A61P 37/00 Drugs for immunological or allergic disorders

Event Publications

9 August 2012 PCT application entered the National Phase

  PCT publication WO2011/097087 Priority application(s): WO2011/097087

13 September 2012 Amendment Made

  The nature of the amendment is: Amend the invention title to read Pyrrolo [2,3-d] pyrimidine urea compounds as JAK inhibitors

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011213202-Drillable bridge plug for high pressure and high temperature environments

2011213196-Systems and methods for processing alloy ingots